Search Results - "BLANCH SANCHO, J. J"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Are there differences between ceftolozane/tazobactam and ceftazidime/avibactam in treating patients with complicated abdominal infections? Evidence from clinical trials by Avilés Martínez, M. C., Alfaro Martínez, J. J., Blanch Sancho, J. J., Solís García del Pozo, J.

    Published in Journal of chemotherapy (Florence) (03-10-2022)
    “…Ceftolozane/tazobactam (C/T) and ceftazidime/avibactam (CZA) are new possibilities of antimicrobial treatment that combined a β-lactam with a β-lactamase…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Dual dosage individualization of vancomycin therapy to treat Staphylococcus epidermidis intraperitoneal vascular paraprosthetic abscesses by Gerónimo-Pardo, Manuel, Mateos-Rodrı́guez, Fernando, Blanch-Sancho, José Javier, Martı́nez-Alfaro, Elisa

    “…The preferred management of bacterial abscesses is therapeutic drainage. However, when drainage is believed to involve considerable risk, prolonged…”
    Get full text
    Journal Article
  4. 4

    An open comparison of the diabetogenic effect of deflazacort and prednisone at a dosage ratio of 1.5 mg:1 mg by Sáez Barcelona, J A, Carmona Martín, M, Navarro López, V, Blanch Sancho, J J, Puras Tellaeche, A

    Published in European journal of clinical pharmacology (01-04-1999)
    “…To compare the diabetogenic effects of deflazacort (D) versus prednisone (PN) using a dosage ratio of 1.5 mg deflazacort:1 mg prednisone. Thirty-three patients…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Glucocorticoid treatment improves glucose tolerance in patients with temporal arteritis or polymyalgia rheumatica by Sáez Barcelona, J A, Carmona Martín, M, Navarro López, V, Blanch Sancho, J J, Puras Tellaeche, A

    Published in Revista clínica espanõla (01-05-1999)
    “…Corticosteroid therapy has been shown to improve glucose tolerance in some connective tissue diseases. This fact has been inadequately investigated in…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    An open comparision of the diabetogenic effect of deflazacort and prednisone at a dosage ratio of 1.5mg:1mg by Barcelona, J A Sáez, Martín, M Carmona, López, V Navarro, Sancho, J J Blanch, Tellaeche, A Puras

    Published in European journal of clinical pharmacology (01-04-1999)
    “…Objective: To compare the diabetogenic effects of deflazacort (D) versus prednisone (PN) using a dosage ratio of 1.5mg deflazacort:1mg prednisone. Methods:…”
    Get full text
    Journal Article